The control of epidemics requires cross-sectoral engagement across various fields such as health, government, international law and security, at both national and international levels. The changing global landscape poses an increased threat to biosecurity, calling for cross-sectoral collaborative research and engagement. Integrated Systems for Epidemic Response (ISER) will convene and lead multidisciplinary systems research in epidemic response.
Protecting The Public From Emerging Infectious Diseases
Funder
National Health and Medical Research Council
Funding Amount
$2,500,000.00
Summary
Emerging infectious diseases and pandemics cause potentially enormous but unpredictable health and socioeconomic impacts. This CRE will develop and integrate new technologies, including fingerprinting the entire gene complement of micro-organisms and new electronic communication platforms, to improve the precision and speed of public health responses. We will develop ethics research-based policy frameworks to enable implementation of these technologies into public health practice and policy.
Reducing The Health, Social And Economic Burden Of Injecting Drug Use In Australia
Funder
National Health and Medical Research Council
Funding Amount
$2,606,037.00
Summary
Injecting drug use (IDU) is a disproportionately large source of health and social harm. This CRE unites Australia’s leading scientists in the IDU field – researchers working on blood-borne virus epidemiology and treatment, overdose prevention, justice health and psychiatric health - and experts from key non-government organisations. The CRE will develop new ways to improve the health of injecting drug users, and reduce the health and social burden of IDU to the Australian community.
Immunisation In Under Studied And Special Risk Populations: Closing The Gap In Knowledge Through A Multidisciplinary Approach
Funder
National Health and Medical Research Council
Funding Amount
$2,499,969.00
Summary
Much of the vaccine research which informs national policy is conducted by the pharmaceutical industry or by government. However, there are critical research gaps in special-risk and under-served populations where targeted research is not commercially viable. These include research in the extremes of age, Indigenous Australians, migrants, refugees, immunosuppressed and traveller populations. This CRE will address research gaps in such populations, which have not been addressed elsewhere, using n ....Much of the vaccine research which informs national policy is conducted by the pharmaceutical industry or by government. However, there are critical research gaps in special-risk and under-served populations where targeted research is not commercially viable. These include research in the extremes of age, Indigenous Australians, migrants, refugees, immunosuppressed and traveller populations. This CRE will address research gaps in such populations, which have not been addressed elsewhere, using novel, multidisciplinary methods.Read moreRead less
Centre For Research Excellence In Critical Infectious Diseases
Funder
National Health and Medical Research Council
Funding Amount
$2,623,406.00
Summary
Severe infection kills millions of people every year, but clinicians and policy makers rarely get the information they need in time to make potentially life-saving decisions about infection. We will apply modern genomics and information systems to better understand infection threats in critical care environments and explore the ethical and medicolegal aspects that may either facilitate or present barriers to important research and time-critical decision making.
From Broome To Berrima: Building Australia-wide Research Capacity In Indigenous Offender Health And Health Care Delivery
Funder
National Health and Medical Research Council
Funding Amount
$3,018,575.00
Summary
Australia has the highest Indigenous incarceration rate in the OECD which impacts profoundly on Indigenous communities. Further, offender populations endure a greater health burden compared with the general community. This grant develops much needed capacity in offender health research, building a team of Indigenous researchers, and creating an Australia-wide network for sharing knowledge in this field. Outcomes will include better Indigenous offender health services and improved health and well ....Australia has the highest Indigenous incarceration rate in the OECD which impacts profoundly on Indigenous communities. Further, offender populations endure a greater health burden compared with the general community. This grant develops much needed capacity in offender health research, building a team of Indigenous researchers, and creating an Australia-wide network for sharing knowledge in this field. Outcomes will include better Indigenous offender health services and improved health and wellbeing for this marginalised population.Read moreRead less
Australian Partnership (for) Preparedness Research On InfectiouS (disease) Emergencies (APPRISE)
Funder
National Health and Medical Research Council
Funding Amount
$4,996,416.00
Summary
We have assembled national experts in clinical, laboratory and public health research to ensure Australia is equipped for a coordinated, effective and evidence based response to infectious diseases. This multidisciplinary team will create and share new knowledge to detect, prevent and manage emerging infection threats. We will train a robust cross-sectoral work force and develop sustainable research capacity integrated within the health system to ensure national and regional health security.
Asia-Pacific Pneumococcal Disease Control In The Pneumococcal Conjugate Vaccine Era
Funder
National Health and Medical Research Council
Funding Amount
$2,500,000.00
Summary
Pneumonia is one of the commonest causes of childhood death worldwide. PCV is a vaccine that prevents pneumonia but it is costly; and causes an increase in disease from strains which are not in the vaccine. Our CRE will address 2 outstanding issues: when to switch from a 3 to 2 dose PCV schedule to make it more affordable; and create new understanding of the non-vaccine strains’ impact on disease in low- and middle-income countries in the Asia-Pacific region.
Centre Of Research Excellence In Infectious Diseases Modelling To Inform Public Health Policy
Funder
National Health and Medical Research Council
Funding Amount
$2,600,064.00
Summary
Infectious diseases pose a global challenge, with substantial human and economic costs. Mathematical models provide valuable frameworks to assess likely benefits of interventions to control infection spread and burden. Leveraging existing NHMRC support, we will expand modeling capability to inform infectious disease control policy in Australia and our region. Focus areas include vaccine preventable disease, respiratory viruses and emerging pathogens, supported by innovative methods development.
National Centre For Research Excellence In Neuromuscular Disorders: Transforming The Management Of Neuromuscular Disorders From Compassionate Assistance To Targeted Therapy And Prevention
Funder
National Health and Medical Research Council
Funding Amount
$2,805,509.00
Summary
Neuromuscular disorders affect 1 in 1,000 people, often result in progressive muscle weakness and can cause early death. At present not enough is being done to ensure translation of research into improved outcomes for patients. For the first time in Australia, the CRE-NMD will establish an integrated, comprehensive program to investigate diagnosis, prevention and treatment of neuromuscular disorders from infancy to adulthood.